论文部分内容阅读
目的 :研究胃癌联合脾胰体尾切除病例术后的远期疗效。方法 :统计50例胃癌患者联合脾胰体尾切除病例5年生存率并与未行脾胰体尾切除的病例进行比较。结果 :单纯胃癌根治术和胃癌联合脾胰体尾切除两组5年生存率无显著差异(t=0 83,P>0 05)。结论 :按肿块边缘距脾门的最近距离≤5 0cm、4s组淋巴结疑有转移或冰冻证实有癌转移、肿块呈浸润性生长并接近脾门指征 ,行癌肿联合脾胰体尾切除 (不包括全胃 ) ,可有效清除脾门区转移淋巴结 ,本组患者的远期疗效接近未行脾胰体尾切除组病例。比较两组生存期无显著差异(P>0 05)。
Objective: To study the long-term curative effect of gastric cancer combined with splenectomy and pancreatic tail resection. Methods: The 5-year survival rate of 50 patients with gastric cancer combined with spleen-pancreatic resection and end-stage resection was statistically compared with those without splenectomy. Results: There was no significant difference in 5-year survival between radical gastrectomy and gastric cancer combined with spleen-pancreatic resection (t = 0 83, P> 0.05). Conclusion: According to the nearest edge of the tumor from the spleen door ≤5 0cm, 4s lymph node metastasis or suspicion of suspected metastasis, the tumor was infiltrative growth and close to splenic indications, combined with cancer of the spleen and pancreatectomy ( Not including the whole stomach), can effectively remove the splenic lymph node metastasis, the long-term efficacy of this group of patients close to the spleen and pancreatic resection group did not. There was no significant difference in survival between the two groups (P> 0.05).